Published
ABC News’ Stephanie Ramos has the latest on Pfizer’s long-awaited data for its vaccine for children 6 months to under 5 years old.
READ MORE: https://abcn.ws/3MJjN34
#ABCNews #Pfizer #Vaccine #COVID19
READ MORE: https://abcn.ws/3MJjN34
#ABCNews #Pfizer #Vaccine #COVID19
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
02:10
Experts: Pfizer's calls for third COVID-19 vaccine dose comes too early in global campaign
-
02:13
Pfizer says vaccine data for younger children delayed
-
1:04:37
COVID-19: BC moves to 8-week gap for second Pfizer or Moderna vaccine dose | FULL
-
01:41
Pfizer expected to release new data on COVID vaccine for kids under 5 l GMA
-
04:37
Single-dose vaccine effective against COVID-19 variants, data shows | WNT
-
04:13
Pfizer requests emergency use for its vaccine for young children l ABCNL
-
03:11
Pfizer asked the FDA for emergency use for its COVID-19 vaccine for children under the age of 5
-
08:01
Medical expert discusses delay in reviewing Pfizer vaccine in young children
-
01:07
Pfizer COVID vaccine safe for younger kids, data shows
-
03:53
Pfizer requests vaccine authorization for children as young as 6 months
-
03:34
Pfizer submits data to FDA on vaccines for young children | WNT
-
05:34
Pfizer's CEO on preliminary COVID-19 vaccine data
-
06:53
Pfizer: COVID-19 vaccine is safe and effective for children as young as 5
-
06:10
Pfizer's 3-dose COVID vaccine 80% effective, people should be 'vigilant' on monkeypox l ABCNL
-
02:45
Pfizer releases data on possible 1st maternal RSV vaccine l GMA
-
04:45
Children under 12 could receive Pfizer's COVID-19 vaccine by Friday
-
01:35
FDA advisers back Pfizer’s COVID-19 vaccine for young kids
-
07:33
Pfizer says COVID-19 vaccine is safe for children ages 5 to 11
-
03:37
Pfizer reports data on 3-dose COVID-19 vaccine for children under five
-
05:54
Pfizer requests emergency authorization for COVID vaccines for young children
-
22:08
Global National: Jan. 16, 2021 | Mixed messages from Pfizer on COVID-19 vaccine dose reduction
-
10:26
Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
Loading...